Virology Research Hub

Access peer-reviewed studies, experimental data, and scientific analysis on viral pathogens

Research Articles

HIV and Apoptosis of Cancer Cells: The Killer's Promises

Exploring how HIV research is revealing new possibilities for cancer treatment through apoptosis manipulation

Isaac Henderson
Oct 22, 2025

Cancer Immunotherapy: Turning the Body Into a Weapon Against Disease

Explore the revolutionary field of cancer immunotherapy, how it works, breakthrough treatments, and future directions in personalized cancer care.

Nolan Perry
Oct 17, 2025

HER2/neu: From Cancer Enemy to Treatment Target - The Revolutionary Science Behind a Groundbreaking Therapy

Explore the fascinating story of HER2/neu antigen, from its discovery as a cancer biomarker to revolutionary targeted therapies that transformed cancer treatment.

Amelia Ward
Oct 15, 2025

The Silent Liver's Secret: Why Women Are Winning the Fight Against Hepatitis C

Discover how women have a biological advantage in clearing Hepatitis C virus, reducing their risk of liver cirrhosis and cancer.

Dylan Peterson
Oct 15, 2025

The Cellular Hijacker: How a Cancer-Causing Virus Switches Off Our Genes

Discover how the HTLV-1 virus causes cancer by silencing the ZNF268 gene through the CREB/ATF pathway - a fascinating look at viral oncogenesis.

Thomas Carter
Oct 08, 2025

The Gentle Giant: How a Childhood Foe Surprised Scientists by Not Causing Cancer

Discover how the measles virus, despite its potency as a disease, revealed a surprisingly gentle side in the lab, helping to calm fears about its cancer-causing potential.

Harper Peterson
Oct 07, 2025

The Hidden Virus and the Cancer It Causes: Mapping KSHV Research

Explore the global research landscape of KSHV/HHV8, an overlooked virus causing nearly 200,000 cancers annually, through bibliometric analysis and scientific breakthroughs.

Charlotte Hughes
Oct 05, 2025

The 8-Week Revolution: Short-Duration Antivirals Transform Care for Cancer Patients with Hepatitis C

Breakthrough research shows 8-week DAA therapy achieves 100% cure rates in HCV-infected cancer patients, enabling faster oncology treatment without delays.

Caleb Perry
Aug 10, 2025

Popular Articles